The innovative drug sector is weakening, with Yuekang Pharmaceutical falling more than 12%.

Innovative drug sector weakened, Yuekang Pharmaceutical fell more than 12%, Guangshengtang, Cubilose Pharmaceutical fell more than 8%, Sali Medical, and Shu Taishen followed the decline.